Discovery of Novel 5-(Pyridazin-3-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Ecto-5'-nucleotidase.
第一作者:
Yu,Xu
第一单位:
Center of Drug Discovery, Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China Pharmaceutical University, Nanjing 210009, China.
作者:
主题词
5'-核苷酸酶(5'-Nucleotidase);动物(Animals);投药, 口服(Administration, Oral);人类(Humans);大鼠(Rats);小鼠(Mice);女(雌)性(Female);构效关系(Structure-Activity Relationship);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);酶抑制剂(Enzyme Inhibitors);哒嗪类(Pyridazines);男(雄)性(Male);药物发现(Drug Discovery);小鼠, 近交BALB C(Mice, Inbred BALB C);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);生物利用度(Biological Availability);微粒体, 肝(Microsomes, Liver);嘧啶类(Pyrimidines);嘧啶酮类(Pyrimidinones);GPI连接蛋白质类(GPI-Linked Proteins)
DOI
10.1021/acs.jmedchem.4c01793
PMID
39385716
发布时间
2024-10-24
- 浏览0

Journal of medicinal chemistry
18491-18511页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文